In Stock

Veopoz (pozelimab-bbfg)

By
CHEMMEDIX

Category:

Description

What is Veopoz (pozelimab-bbfg) for?

Veopoz (pozelimab-bbfg) is a prescription medicine for children older than 1 year and adults, who have CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease[1].

Veopoz is available as a subcutaneous injection (400 mg/2 mL)[1].

How does Veopoz (pozelimab-bbfg) work?

Pozelimab-bbfg is a specially designed human-made antibody that targets a specific protein called C5. By doing so, it stops a process that can harm cells. This process involves breaking C5 into two parts (C5a and C5b) and then creating a structure that can destroy cells (the membrane-attack complex C5b-C9). By blocking this process, pozelimab-bbfg helps protect cells[1].

Where has Veopoz (pozelimab-bbfg) been approved?

Veopoz (pozelimab-bbfg) is currently approved by the FDA in the USA[2].

Reviews

There are no reviews yet.

Be the first to review “Veopoz (pozelimab-bbfg)”

Your email address will not be published. Required fields are marked *

Use the form to Request for this Medicine

Please enable JavaScript in your browser to complete this form.
Name
Are you a...